Kathryn E. Follis

University of Montana — United States

Immunology and Microbiology · Life Sciences

16h-index1.9kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(20), HIV/AIDS Research and Interventions(11), HIV/AIDS drug development and treatment(10), Immune Cell Function and Interaction(5), T-cell and B-cell Immunology(3)

Publications25 total

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry
Virology·2006· 252 cited
Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region
Virology·2005· 10 cited
Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus
Virus Research·2004· 11 cited
Genetic Evidence that Interhelical Packing Interactions in the gp41 Core Are Critical for Transition of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein to the Fusion-Active State
Journal of Virology·2002· 56 citedOpen Access
Antibody Binding and Neutralization of Primary and T-Cell Line-Adapted Isolates of Human Immunodeficiency Virus Type 1
Journal of Virology·2001· 53 citedOpen Access
Post‐exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection
Journal of Medical Primatology·2000· 29 cited
Turning a corner on HIV neutralization?
Microbes and Infection·2000· 11 cited
Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV
Science·1999· 210 cited
Continued Utilization of CCR5 Coreceptor by a Newly Derived T-Cell Line-Adapted Isolate of Human Immunodeficiency Virus Type 1
Journal of Virology·1998· 10 citedOpen Access
Effectiveness of Postinoculation ( <i>R</i> )-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIV <sub>mne</sub> Infection Depends Critically on Timing of Initiation and Duration of Treatment
Journal of Virology·1998· 317 citedOpen Access
Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity
Journal of Virology·1998· 54 citedOpen Access
Effects of ( <i>R</i> )-9-(2-Phosphonylmethoxypropyl)adenine Monotherapy on Chronic SIV Infection in Macaques
AIDS Research and Human Retroviruses·1997· 67 cited
Antiviral efficacy of PMPA in macaques chronically infected with SIV
Antiviral Research·1996· 11 cited
Prevention of SIV Infection in Macaques by ( <i>R</i> )-9-(2-Phosphonylmethoxypropyl)adenine
Science·1995· 561 cited
Efficacy of 9-(2-Phosphonylmethoxyethyl)adenine Treatment against Chronic Simian Immunodeficiency Virus Infection in Macaques
The Journal of Infectious Diseases·1995· 32 cited
Comparison of the efficacy of AZT and PMEA treatment against acute SIV<sub>mne</sub> infection in macaques
Journal of Medical Primatology·1994· 23 cited
Preexposure Prophylaxis with 9-(2-Phosphonylmethoxyethyl)adenine against Simian Immunodeficiency Virus Infection in Macaques
The Journal of Infectious Diseases·1994· 46 cited
Infectivity and pathogenesis of titered dosages of simian immunodeficiency virus experimentally inoculated into longtailed macaques (Macaca fascicularis).
PubMed·1993· 16 cited
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.
PubMed·1993· 25 cited
In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)
Antiviral Research·1990· 20 cited
page 1 of 2Next →

Frequent Co-authors

Che‐Chung Tsai(14), Jack H. Nunberg(9), Richard Grant(7), Raoul Ė. Benveniste(7), Norbert Bischofberger(6), Thomas W. Beck(5), Meg Trahey(5), Alexander Sabó(4), Rachel LaCasse(4), R. E. Nolte(4), Michele Yarnall(4), William R. Morton(3), Joanne York(3), Roberta Black(2), Peter Emau(2), Peter J. Dailey(2), Susan Zolla‐Pazner(2), A Sabó(2), N. Bischofberger(2), C. R. Bartz(2)